Diagnostic Issues of Depressive Disorders from Kraepelinian Dualism to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition

키워드

참고문헌 (88)

1. Adam D, "Mental health : on the spectrum", Nature, 496, pp.416~428 (2013)
2. Shorter E, "Making the DSM-5: Concepts and Controversies", pp.3~20 (2013), Springer Nature
3. Sadler JZ, "Making the DSM-5: Concepts and Controversies", pp.21~38 (2013), Springer Nature
4. Insel TR, "Next-generation treatments for mental disorders", Sci Transl Med, 4, pp.155~ (2012)[DOI]
5. Insel TR, "Brain disorder? Precisely", Science, 348, pp.499~500 (2015)
6. Miller G, "Beyond DSM : seeking a brain-based classification of mental illness", Science, 327, pp.1437~ (2010)
7. Whooley O, "Paradox of Professional Success: Grand Ambition, Furious Resistances, and the Derailment of the DSM-5 Revision Process", pp.75~92 (2013), Springer Nature
8. Assembly of the American Psychiatric Association, "Motion on cross-cutting dimensions and severity scales", Passed at the annual meeting of American Psychiatric Association (2012)
9. Frances A, "Diagnosing the DSM", The New York Times, ~ (2012)
10. Kupfer DJ, "Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5", Am J Psychiatry, 168, pp.672~674 (2011)
11. Uher R, "Depression symptom dimensions as predictors of antidepressant treatment outcome : Replicable evidence for interest-activity symptoms", Psychol Med, 42, pp.967~980 (2012)
12. Park SC, "Understanding Depression: Volume 2. Clinical Manifestations, Diagnosis and Treatment", pp.3~14 (2018), Springer Nature
13. Ghaemi SN, "One Century of Karl Jaspers’ General Psychopathology", pp.245~257 (2013), Oxford University Press
14. Engstrom EJ, "Emil Kraepelin : icon and reality", Am J Psychiatry, 172, pp.1190~1196 (2015)
15. Kendler KS, "Criticisms of Kraepelin’s psychiatric nosology : 1896-1927", Am J Psychiatry, 175, pp.316~326 (2018)
16. Seon-Cheol Park, "Karl Jaspers’ General Psychopathology (Allgemeine Psychopathologie) and Its Implication for the Current Psychiatry", PSYCHIATRY INVESTIGATION, 16(2), pp.99~108 (2019), 대한신경정신의학회[DOI]
17. Lichtenstein P, "Common genetic determinants of schizophrenia and bipolar disorder in Swedish families : a population-based study", Lancet, 373, pp.234~239 (2009)
18. Rasic D, "Risk of mental illness in off-spring of parents with schizophrenia, bipolar disorder, and major depressive disorder : a meta-analysis of family high-risk studies", Schizophr Bull, 40, pp.28~38 (2013)
19. Cross-Disorder Group of the Psychiatric Genomics Consortium, "Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs", Nat Genet, 45, pp.984~994 (2013)
20. Berk M, "Diagnosing bipolar disorder: how can we do it better?", Med J Aust, 184, pp.459~462 (2016)
21. Etain B, "Clinical expression of bipolar disorder type I as a function of age and polarity at onset : convergent findings in samples from France and the United States", J Clin Psychiatry, 73, pp.e561~e566 (2012)
22. Moller HJ, "DSM-5 reviewed from different angles : goal attainment, rationality, use of evidence, consequence-Part 1 : general aspects and paradigmatic discussion of depressive disorders", Eur Arch Psychiatry Clin Neurosci, 265, pp.5~18 (2015)
23. Zimmerman M, "A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder", J Affect Disord, 168, pp.357~362 (2014)
24. Koulopoulos A, "Mixed features of depression: why DSM-5 is wrong (and so was DSM-IV)", Br J Psychiatry, 203, pp.3~5 (2013)
25. Young-Min Park, "The Mixed-Features Specifier of Major Depressive Disorder in DSM-5: Is It Practical?", PSYCHIATRY INVESTIGATION, 15(11), pp.1009~1010 (2018), 대한신경정신의학회[DOI]
26. In Hee Shim, "Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review", Clinical Psychopharmacology and Neuroscience, 16(4), pp.376~382 (2018), 대한정신약물학회[DOI]
27. Shim IH, "The prevalence and diagnostic classification of mixed features in patients with major depressive episodes: a multicenter study based on the DSM-5", Int J Methods Psychiatr Res, pp.e1773~ (2019)
28. Greene GM, "The relationship between depression and hopelessness : implications for current theories of depression", Br J Psychiatry, 154, pp.650~659 (1993)
29. Beck AT, "Hopelessness, depression, suicidal ideation, and clinical diagnosis of depression", Suicide Life Threat Behav, 23, pp.139~145 (1993)
30. Joiner TE Jr, "Hopelessness depression as a distinct dimension of depressive symptoms among clinical and non-clinical samples", Behav Res Ther, 39, pp.523~536 (2001)
31. Zisook S, "The bereavement exclusion and DSM-5", Depress Anxiety, 29, pp.425~443 (2012)
32. Bandini J, "The medicalization of bereavement : (Ab)normal grief in the DSM-5", Death Stud, 39, pp.347~352 (2015)
33. Pies RW, "The bereavement exclusion and DSM-5 : an update and commentary", Innov Clin Neurosci, 11, pp.19~22 (2014)
34. Zimmerman M, "A simpler definition of major depressive disorder", Psychol Med, 40, pp.451~457 (2010)
35. Østergaard SD, "The heterogeneity of the depressive syndrome : when numbers get serious", Acta Psychiatr Scand, 124, pp.495~496 (2011)
36. Zimmerman M, "How many different ways do patients meet the diagnostic criteria for major depressive disorder", Compr Psychiatry, 56, pp.29~34 (2015)
37. Park SC, "How many different symptom combinations fulfill the diagnostic criteria for major depressive disorder? : results from the CRESCEND study", Nord J Psychiatry, 71, pp.217~222 (2017)
38. Rosenman S, "Psychiatric diagnoses are not mental processes : Wittgenstein on conceptual confusion", Aust N Z J Psychiatry, 46, pp.1046~1052 (2012)
39. Wittgenstein L, "Philosophical Investigations" (2001), Blackwell
40. Armour C, "PTSD symptomics: network analyses in the field of psychotraumatology", Eur J Psychotraumatol, 8(sup3), pp.1398003~ (2017)
41. Fried EI, "Moving forward : how depression heterogeneity hinders progress in treatment and research", Expert Rev Neurother, 17, pp.423~425 (2017)
42. Bentall RP, "Do specific early-life adversities lead to specific symptoms of psychosis? A study from the 2007 the adult psychiatric morbidity survey", Schizophr Bull, 38, pp.734~740 (2012)
43. Fried EI, "Depression is not a consistent syndrome : an investigation of unique symptom patterns in the STAR*D study", J Affect Disord, 172, pp.96~102 (2015)
44. Hieronymus F, "Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression", Mol Psychiatry, 21, pp.523~530 (2016)
45. Persons JB, "The advantages of studying psychological phenomena rather than psychiatric diagnoses", Am Psychol, 41, pp.1252~1260 (1986)
46. Contreas A, "The study of psychopathology from the network analysis perspective : a systematic review", Psychother Psychosom, 88, pp.71~83 (2019)
47. Fried EI, "What are ‘good’ depressive symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis", J Affect Disord, 189, pp.314~320 (2016)
48. Opsahl T, "Node centrality in weighted networks : generalizing degrees and shortest paths", Soc Netw, 32, pp.245~251 (2010)
49. van Borkulo C, "Association of symptom network structure with the course of longitudinal depression", JAMA Psychiatry, 72, pp.1219~1226 (2015)
50. Madhoo M, "Network analysis of the Quick Inventory of Depressive Symptomatology : Reanalysis of the STAR*D clinical trial", Eur Neuropsychopharmacol, 26, pp.1768~1774 (2016)
51. Cramer AO, "The psychopathology of dysphoric episodes : differential impact of stressful life events on the pattern of depressive symptom inter-correlations", Psychol Med, 42, pp.957~965 (2012)
52. Santos H Jr, "Network structure of perinatal depressive symptoms in Latinas : relationship to stress and reproductive biomarkers", Res Nurs Health, 40, pp.218~228 (2017)
53. McWilliams LA, "A network analysis of depressive symptoms individuals seeking treatment for chronic pain", Clin J Pain, 33, pp.899~904 (2017)
54. Park SC, "Major Depressive Disorder: Risk Factors, Characteristics and Treatment Options", pp.49~67 (2017), NOVA Science Publishers Inc
55. Østergaard SD, "Considerations on the ICD-11 classification of psychotic depression", Psychother Psychosom, 81, pp.135~144 (2012)
56. Keller J, "Current issues in the classification of psychotic major depression", Schizophr Bull, 33, pp.877~885 (2007)
57. Glassman AH, "Delusional depression: a distinct clinical entity?", Arch Gen Psychiatry, 138, pp.831~833 (1981)
58. Lykouras E, "Delusional depression: phenomenology and response to treatment. A prospective study", Acta Psychiatr Scand, 73, pp.324~329 (1986)
59. Frances A, "Psychotic depression: a separate entity?", Am J Psychiatry, 138, pp.831~833 (1981)
60. Zaninotto L, "Cognitive markers of psychotic unipolar depression : a meta-analytic study", J Affect Disord, 174, pp.580~588 (2015)
61. Hill SK, "Neuropsychological dysfunction in antipsychotic-naïve first-episode unipolar psychotic depression", Am J Psychiatry, 161, pp.996~1003 (2014)
62. Anton RF, "Urinary free cortisol in psychotic depression", Biol Psychiatry, 22, pp.24~34 (1987)
63. Nelson JC, "DST studies in psychotic depression : a meta-analysis", Am J Psychiatry, 154, pp.1497~1503 (1997)
64. Rosthschild AJ, "The dexamethasone suppression test as a discriminator among subtypes of psychotic patients", Br J Psychiatry, 141, pp.471~474 (1982)
65. Schatzberg AF, "The dexamethasone suppression test : Identification of subtypes of depression", Am J Psychiatry, 140, pp.88~91 (1983)
66. Kim DK, "Candidate neuroanatomic substrates of psychosis in old-aged depression", Prog Neuropsychopharmacol Biol Psychiatry, 23, pp.793~807 (1999)
67. Salokangas RK, "Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls : results of the schizophrenia and affective psychoses(SAP)project", Br J Psychiatry Suppl, 43, pp.S58~S65 (2012)
68. Simpson S, "The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression : comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features", Biol Psychiatry, 45, pp.193~204 (1999)
69. Cubells JF, "Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression", Biol Psychiatry, 51, pp.358~364 (2002)
70. Meyers BS, "Decreased dopamine beta-hyrodoxylase activity in unipolar geriatirc delusional depression", Biol Psychiatry, 45, pp.448~452 (1999)
71. Block TS, "Combined analysis of mifepristone for psychotic depression : plasma levels associated with clinical response", Biol Psychiatry, 84, pp.46~54 (2018)
72. Østergaard SD, "The validity of severity-psychosis hypothesis in depression", J Affect Disord, 140, pp.48~56 (2012)
73. Maj M, "Phenomenology and prognostic significance of delusions in major depressive disorder : a 10-year prospective follow-up study", J Clin Psychiatry, 68, pp.1411~1417 (2007)
74. Ohayon MM, "Prevalence of depressive episodes with psychotic features in general population", Am J Psychiatry, 159, pp.1855~1861 (2002)
75. Tamminga CA, "Deconstructing Psychosis: Refining the Research Agenda for DSM-V", American Psychiatric Association, ~ (2010)
76. Østergaard SD, "Rating scale measuring the severity of psychotic depression", Acta Psychiatr Scand, 132, pp.335~344 (2015)
77. Østergaard SD, "Measuring psychotic depression", Acta Psychiatr Scand, 129, pp.211~220 (2014)
78. Østergaard SD, "Measuring treatment response in psychotic depression : he psychotic depression assessment scale(PDAS)takes both depressive and psychotic symptoms into account", J Affect Disord, 160, pp.68~73 (2014)
79. Østergaard SD, "Clinical and psychometric validation of the psychotic depression assessment scale", J Affect Disord, 173, pp.261~268 (2015)
80. Østergaard SD, "Establishing the cut-off score for remission and severity-ranges on the psychotic depression assessment scale (PDAS)", J Affect Disord, 190, pp.111~114 (2016)
81. Leadholm AK, "The treatment of psychotic depression: is there consensus among guidelines and psychiatrists?", J Affect Disord, 145, pp.214~220 (2013)
82. Park SC, "Is the psychotic depression assessment scale a useful diagnostic tool? : the CRESCEND Study", J Affect Disord, 166, pp.79~85 (2014)
83. Park SC, "Is the BPRS-5 subscale of the psychotic depression assessment scale a reliable screening tool for psychotic depression? : results from the CRESCEND Study", J Affect Disord, 174, pp.188~191 (2015)
84. 박선철, "Clinical Validation of the Psychotic Depression Assessment Scale, Hamilton Depression Rating Scale-6, and Brief Psychiatric Rating Scale-5: Results from the Clinical Research Center for Depression Study", PSYCHIATRY INVESTIGATION, 14(5), pp.568~576 (2017), 대한신경정신의학회[DOI]
85. Goldberg D, "Diagnostic Issues in Depression and Generalized Anxiety Disorder: Refining the Research Agenda for DSM-V", American Psychiatric Association, ~ (2010)
86. Starcevic V, "The status quo as a good outcome : how the DSM-5 diagnostic criteria for generalized anxiety disorder remained unchanged from the DSM-IV criteria", Aust N Z J Psychiatry, 47, pp.995~997 (2013)
87. Karlsson B, "DSM-IV and DSM-5 prevalence of social anxiety disorder in a population sample of older people", Am J Geriatr Psychiatry, 24, pp.1237~1245 (2016)
88. Gaspesz R, "Longitudinal predictive validity of the DSM-5 anxious distress specifier for clinical outcomes in a large cohort of patients with major depressive disorder", J Clin Psychiatry, 78, pp.207~213 (2017)

관련 논문AI추천